4-Aminopyridine

Specifications

504-24-5CAS Number

207-987-9EC Number

pyridin-4-amineIUPAC Name

C5H6N2Chemical Formula

94.11 g/molMolecular Weight

4-aminopyridine; 504-24-5; pyridin-4-amine; 4-Pyridinamine; Fampridine; Dalfampridine; 4-Pyridylamine; Avitrol; p-Aminopyridine; Ampyra; gamma-Aminopyridine; Amino-4 pyridine; Avitrol 200; FAMPYRA; Phillips 1861; Neurelan; 4 Aminopyridine; Fampridine-SR; fampridina; VMI 10-3; EL-970; DTXSID0023870; Mi-W-3; fampridinum; NSC-15041; VMI 103; BH3B64OKL9; 1,4-dihydropyridin-4-imine; N07XX07; Fampridine (4-aminopyridine); DTXCID003870; CHEBI:34385; 5-22-09-00106 (Beilstein Handbook Reference); NSC15041; Pymadine; Fampridine SR; VMI103; 4 Aminopyridine Sustained Release; Sustained Release, 4-Aminopyridine; Ampyra Extended Release; RefChem:54927; 207-987-9; 4-AP; Pyridine, 4-amino-; Pimadin (free base); Compound 1861; Amaya; Prc 1237; pyridin-4-ylamine; NSC 15041; Fampridine [INN]; .gamma.-Aminopyridine; Dalfampridine [USAN]; MFCD00006439; MLS000069400; CHEMBL284348; Dalfampridine (USAN); NCGC00015009-08; SMR000058211; ACETYL-2-13C CHLORIDE,2,2-DICHLORO- (9CI); Caswell No. 038; VMI-103; 4-amino pyridine; 4-amino-pyridine; 4- Aminopyridine; CAS-504-24-5; Ampyra (TN); HSDB 6037; SR-01000075299; EINECS 207-987-9; RCRA waste no. P008; UNII-BH3B64OKL9; EPA Pesticide Chemical Code 069201; Dalfampridine [USAN:INN]; BRN 0105782; Frampridine; Ampydin; BIIB041; Pymadin; AI3-52547; BIIB 041; Fampridine-PR; Dalfampridine (4-aminopyridine); Dalfampridine-ER; 4-pyridyl amine; para-aminopyridine; pyridine-4-amine; 3rxf; Neurelan (TN); pyridine-4-ylamine; 4AP; VMI-10-3; Fampyra (TN); pyridin-4-yl-amine; 4-Aminopyridine 10; Philips 1861; 4-AMINOPYRDINE; Spectrum_000155; Tocris-0940; Fampridine (JAN/INN); 4-Aminopyridine, 98%; FAMPRIDINE [JAN]; PYRIDINE,4-AMINO; Opera_ID_1768; Spectrum2_001413; Spectrum3_000914; Spectrum4_001013; Spectrum5_001501; Lopac-A-0152; DALFAMPRIDINE [II]; DALFAMPRIDINE [MI]; FAMPRIDINE [VANDF]; UPCMLD-DP125; WLN: T6NJ DZ; 4-Aminopyridine (4-AP); FAMPRIDINE [MART.]; 4-Aminopyridine, >=99%; DALFAMPRIDINE [HSDB]; FAMPRIDINE [WHO-DD]; Lopac0_000032; SCHEMBL53483; BSPBio_001562; DALFAMPRIDINE [VANDF]; KBioGR_000282; KBioGR_001505; KBioSS_000282; KBioSS_000635; 29212-32-6; DivK1c_000572; FAMPRIDINE [EMA EPAR]; SCHEMBL245056; SCHEMBL291100; SCHEMBL332270; SCHEMBL332451; SPECTRUM1501130; SPBio_001486; DALFAMPRIDINE [USP-RS]; 4 AP; BIIB-041; GTPL2416; orb1941039; orb2893743; orb3026006; Pyridin-4-Amine; Dalfampridine; SCHEMBL1397445; SCHEMBL1683855; SCHEMBL3865305; CL-COB-III-274-1; UPCMLD-DP125:001; BDBM10458; HMS501M14; KBio1_000572; KBio2_000282; KBio2_000635; KBio2_002850; KBio2_003203; KBio2_005418; KBio2_005771; KBio3_000563; KBio3_000564; KBio3_001888; NINDS_000572; Bio1_000353; Bio1_000842; Bio1_001331; Bio2_000282; Bio2_000762; HMS1361O04; HMS1791O04; HMS1921H15; HMS1989O04; HMS2092F05; HMS2234N24; HMS3260G05; HMS3267E21; HMS3370J03; HMS3402O04; HMS3414H15; HMS3678H13; HMS3886I09; KUC111877N; Pharmakon1600-01501130; DALFAMPRIDINE [ORANGE BOOK]; HY-B0604; Tox21_110065; Tox21_200793; Tox21_500032; CCG-39031; DALFAMPRIDINE [USP MONOGRAPH]; EBC-03934; HB1073; NSC757845; RB8003; s5028; SBB004393; STK298717; AKOS000119896; Tox21_110065_1; BS-3729; DB06637; FA00151; LP00032; MSK000551-100M; NSC-757845; SDCCGMLS-0066228.P001; SDCCGSBI-0050021.P004; IDI1_000572; IDI1_034032; p-Aminopyridine [UN2671] [Poison]; MSK000551-1000M; NCGC00015009-01; NCGC00015009-02; NCGC00015009-03; NCGC00015009-04; NCGC00015009-05; NCGC00015009-06; NCGC00015009-07; NCGC00015009-09; NCGC00015009-10; NCGC00015009-11; NCGC00015009-12; NCGC00015009-13; NCGC00015009-14; NCGC00015009-16; NCGC00015009-23; NCGC00015009-24; NCGC00015009-25; NCGC00024890-01; NCGC00024890-02; NCGC00024890-03; NCGC00024890-04; NCGC00024890-05; NCGC00024890-06; NCGC00024890-07; NCGC00024890-08; NCGC00024890-09; NCGC00024890-10; NCGC00258347-01; NCGC00260717-01; BP-21343; SBI-0050021.P003; DB-028705; A0414; EU-0100032; NS00002207; ST45053817; EN300-21310; FAMPRIDINE (4-AMINOPYRIDINE) [VANDF]; A 0152; D04127; 4-Aminopyridine Solution in Methanol, 100ug/mL; AB00052209_12; [J.Pharmacol.Exp.Ther. 275:864 (1995)]; 4-Aminopyridine Solution in Methanol, 1000ug/mL; AC-907/25014071; F047207; Q372539; 4-Aminopyridine, PESTANAL(R), analytical standard; SR-01000075299-1; SR-01000075299-3; SR-01000075299-5; BRD-K22482860-001-20-6; BRD-K22482860-001-21-4; F2190-0487; Z104495272; Dalfampridine, United States Pharmacopeia (USP) Reference Standard; InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7Synonyms